nodes	percent_of_prediction	percent_of_DWPC	metapath
Tacrolimus—PPP3CA—Cyclosporine—systemic lupus erythematosus	0.235	0.423	CbGbCtD
Tacrolimus—ALB—systemic lupus erythematosus	0.142	1	CbGaD
Tacrolimus—FKBP1A—Cyclosporine—systemic lupus erythematosus	0.0975	0.176	CbGbCtD
Tacrolimus—CYP3A7-CYP3A51P—Dapsone—systemic lupus erythematosus	0.0144	0.0259	CbGbCtD
Tacrolimus—CYP3A7—Dapsone—systemic lupus erythematosus	0.0144	0.0259	CbGbCtD
Tacrolimus—ALB—Mycophenolate mofetil—systemic lupus erythematosus	0.0116	0.021	CbGbCtD
Tacrolimus—CYP3A5—Dapsone—systemic lupus erythematosus	0.0108	0.0194	CbGbCtD
Tacrolimus—CYP3A7-CYP3A51P—Hydrocortisone—systemic lupus erythematosus	0.01	0.018	CbGbCtD
Tacrolimus—CYP3A7—Hydrocortisone—systemic lupus erythematosus	0.01	0.018	CbGbCtD
Tacrolimus—CYP3A7—Cyclosporine—systemic lupus erythematosus	0.00945	0.017	CbGbCtD
Tacrolimus—CYP3A7-CYP3A51P—Cyclosporine—systemic lupus erythematosus	0.00945	0.017	CbGbCtD
Tacrolimus—CYP3A5—Mycophenolate mofetil—systemic lupus erythematosus	0.00935	0.0169	CbGbCtD
Tacrolimus—ALB—Prednisone—systemic lupus erythematosus	0.0093	0.0168	CbGbCtD
Tacrolimus—ABCB1—Methylprednisolone—systemic lupus erythematosus	0.00803	0.0145	CbGbCtD
Tacrolimus—CYP3A5—Hydrocortisone—systemic lupus erythematosus	0.0075	0.0135	CbGbCtD
Tacrolimus—CYP3A5—Cyclosporine—systemic lupus erythematosus	0.00709	0.0128	CbGbCtD
Tacrolimus—CYP3A7-CYP3A51P—Dexamethasone—systemic lupus erythematosus	0.00622	0.0112	CbGbCtD
Tacrolimus—CYP3A7—Dexamethasone—systemic lupus erythematosus	0.00622	0.0112	CbGbCtD
Tacrolimus—ABCB1—Mycophenolate mofetil—systemic lupus erythematosus	0.00609	0.011	CbGbCtD
Tacrolimus—ABCB1—Betamethasone—systemic lupus erythematosus	0.00522	0.00941	CbGbCtD
Tacrolimus—ABCB1—Prednisolone—systemic lupus erythematosus	0.00515	0.00929	CbGbCtD
Tacrolimus—ABCB1—Hydrocortisone—systemic lupus erythematosus	0.00488	0.0088	CbGbCtD
Tacrolimus—ABCB1—Prednisone—systemic lupus erythematosus	0.00486	0.00877	CbGbCtD
Tacrolimus—CYP3A4—Methylprednisolone—systemic lupus erythematosus	0.00481	0.00867	CbGbCtD
Tacrolimus—CYP3A5—Dexamethasone—systemic lupus erythematosus	0.00467	0.00841	CbGbCtD
Tacrolimus—ALB—Methotrexate—systemic lupus erythematosus	0.00467	0.00841	CbGbCtD
Tacrolimus—ABCB1—Cyclosporine—systemic lupus erythematosus	0.00461	0.00831	CbGbCtD
Tacrolimus—CYP3A4—Dapsone—systemic lupus erythematosus	0.00421	0.00758	CbGbCtD
Tacrolimus—CYP3A4—Mycophenolate mofetil—systemic lupus erythematosus	0.00365	0.00657	CbGbCtD
Tacrolimus—CYP3A4—Triamcinolone—systemic lupus erythematosus	0.00365	0.00657	CbGbCtD
Tacrolimus—CYP3A4—Betamethasone—systemic lupus erythematosus	0.00313	0.00564	CbGbCtD
Tacrolimus—CYP3A4—Prednisolone—systemic lupus erythematosus	0.00309	0.00556	CbGbCtD
Tacrolimus—ABCB1—Dexamethasone—systemic lupus erythematosus	0.00304	0.00548	CbGbCtD
Tacrolimus—CYP3A4—Hydrocortisone—systemic lupus erythematosus	0.00293	0.00528	CbGbCtD
Tacrolimus—CYP3A4—Prednisone—systemic lupus erythematosus	0.00291	0.00525	CbGbCtD
Tacrolimus—CYP3A4—Cyclosporine—systemic lupus erythematosus	0.00276	0.00498	CbGbCtD
Tacrolimus—PPP3CA—blood plasma—systemic lupus erythematosus	0.00257	0.0527	CbGeAlD
Tacrolimus—ABCB1—Methotrexate—systemic lupus erythematosus	0.00244	0.0044	CbGbCtD
Tacrolimus—ABCA5—nephron tubule—systemic lupus erythematosus	0.00197	0.0403	CbGeAlD
Tacrolimus—MTOR—blood plasma—systemic lupus erythematosus	0.0019	0.039	CbGeAlD
Tacrolimus—CYP3A4—Dexamethasone—systemic lupus erythematosus	0.00182	0.00328	CbGbCtD
Tacrolimus—FKBP1A—blood plasma—systemic lupus erythematosus	0.00171	0.035	CbGeAlD
Tacrolimus—ABCA5—cortex of kidney—systemic lupus erythematosus	0.00168	0.0345	CbGeAlD
Tacrolimus—ABCA5—tendon—systemic lupus erythematosus	0.00139	0.0286	CbGeAlD
Tacrolimus—PPP3CA—connective tissue—systemic lupus erythematosus	0.00137	0.0281	CbGeAlD
Tacrolimus—ABCA5—bone marrow—systemic lupus erythematosus	0.00135	0.0277	CbGeAlD
Tacrolimus—PPP3CA—nephron tubule—systemic lupus erythematosus	0.00133	0.0272	CbGeAlD
Tacrolimus—ABCA5—lung—systemic lupus erythematosus	0.00122	0.0251	CbGeAlD
Tacrolimus—PPP3CA—kidney—systemic lupus erythematosus	0.00117	0.0239	CbGeAlD
Tacrolimus—PPP3CA—cortex of kidney—systemic lupus erythematosus	0.00114	0.0233	CbGeAlD
Tacrolimus—ABCA5—nervous system—systemic lupus erythematosus	0.00113	0.0232	CbGeAlD
Tacrolimus—ABCA5—central nervous system—systemic lupus erythematosus	0.00109	0.0224	CbGeAlD
Tacrolimus—CYP3A4—urine—systemic lupus erythematosus	0.00107	0.0219	CbGeAlD
Tacrolimus—MTOR—connective tissue—systemic lupus erythematosus	0.00101	0.0207	CbGeAlD
Tacrolimus—PPP3CA—lymphoid tissue—systemic lupus erythematosus	0.001	0.0205	CbGeAlD
Tacrolimus—PPP3CA—tendon—systemic lupus erythematosus	0.000942	0.0193	CbGeAlD
Tacrolimus—CYP3A7-CYP3A51P—nephron tubule—systemic lupus erythematosus	0.000928	0.019	CbGeAlD
Tacrolimus—MTOR—skin of body—systemic lupus erythematosus	0.000914	0.0187	CbGeAlD
Tacrolimus—PPP3CA—bone marrow—systemic lupus erythematosus	0.000912	0.0187	CbGeAlD
Tacrolimus—FKBP1A—connective tissue—systemic lupus erythematosus	0.00091	0.0187	CbGeAlD
Tacrolimus—MTOR—kidney—systemic lupus erythematosus	0.000862	0.0177	CbGeAlD
Tacrolimus—PPP3CA—lung—systemic lupus erythematosus	0.000827	0.0169	CbGeAlD
Tacrolimus—FKBP1A—skin of body—systemic lupus erythematosus	0.000822	0.0168	CbGeAlD
Tacrolimus—CYP3A7-CYP3A51P—cortex of kidney—systemic lupus erythematosus	0.000794	0.0163	CbGeAlD
Tacrolimus—FKBP1A—kidney—systemic lupus erythematosus	0.000775	0.0159	CbGeAlD
Tacrolimus—PPP3CA—nervous system—systemic lupus erythematosus	0.000765	0.0157	CbGeAlD
Tacrolimus—FKBP1A—cortex of kidney—systemic lupus erythematosus	0.000755	0.0155	CbGeAlD
Tacrolimus—CYP3A5—blood plasma—systemic lupus erythematosus	0.000745	0.0153	CbGeAlD
Tacrolimus—MTOR—lymphoid tissue—systemic lupus erythematosus	0.00074	0.0152	CbGeAlD
Tacrolimus—PPP3CA—central nervous system—systemic lupus erythematosus	0.000737	0.0151	CbGeAlD
Tacrolimus—MTOR—tendon—systemic lupus erythematosus	0.000696	0.0143	CbGeAlD
Tacrolimus—MTOR—bone marrow—systemic lupus erythematosus	0.000674	0.0138	CbGeAlD
Tacrolimus—FKBP1A—lymphoid tissue—systemic lupus erythematosus	0.000666	0.0136	CbGeAlD
Tacrolimus—FKBP1A—tendon—systemic lupus erythematosus	0.000626	0.0128	CbGeAlD
Tacrolimus—MTOR—lung—systemic lupus erythematosus	0.000611	0.0125	CbGeAlD
Tacrolimus—FKBP1A—bone marrow—systemic lupus erythematosus	0.000606	0.0124	CbGeAlD
Tacrolimus—MTOR—nervous system—systemic lupus erythematosus	0.000565	0.0116	CbGeAlD
Tacrolimus—CYP3A4—blood plasma—systemic lupus erythematosus	0.000559	0.0115	CbGeAlD
Tacrolimus—FKBP1A—lung—systemic lupus erythematosus	0.000549	0.0113	CbGeAlD
Tacrolimus—MTOR—central nervous system—systemic lupus erythematosus	0.000544	0.0112	CbGeAlD
Tacrolimus—FKBP1A—nervous system—systemic lupus erythematosus	0.000509	0.0104	CbGeAlD
Tacrolimus—FKBP1A—central nervous system—systemic lupus erythematosus	0.00049	0.01	CbGeAlD
Tacrolimus—ORM1—bone marrow—systemic lupus erythematosus	0.000475	0.00973	CbGeAlD
Tacrolimus—ORM1—lung—systemic lupus erythematosus	0.00043	0.00881	CbGeAlD
Tacrolimus—ORM1—nervous system—systemic lupus erythematosus	0.000398	0.00816	CbGeAlD
Tacrolimus—ABCB1—blood plasma—systemic lupus erythematosus	0.000396	0.00811	CbGeAlD
Tacrolimus—CYP3A5—nephron tubule—systemic lupus erythematosus	0.000384	0.00787	CbGeAlD
Tacrolimus—ORM1—central nervous system—systemic lupus erythematosus	0.000383	0.00786	CbGeAlD
Tacrolimus—CYP3A5—kidney—systemic lupus erythematosus	0.000338	0.00692	CbGeAlD
Tacrolimus—CYP3A5—cortex of kidney—systemic lupus erythematosus	0.000329	0.00674	CbGeAlD
Tacrolimus—CYP3A4—kidney—systemic lupus erythematosus	0.000253	0.00519	CbGeAlD
Tacrolimus—CYP3A5—lung—systemic lupus erythematosus	0.000239	0.0049	CbGeAlD
Tacrolimus—ABCB1—nephron tubule—systemic lupus erythematosus	0.000204	0.00418	CbGeAlD
Tacrolimus—ABCB1—kidney—systemic lupus erythematosus	0.000179	0.00367	CbGeAlD
Tacrolimus—ABCB1—cortex of kidney—systemic lupus erythematosus	0.000175	0.00358	CbGeAlD
Tacrolimus—CYP3A4—nervous system—systemic lupus erythematosus	0.000166	0.00341	CbGeAlD
Tacrolimus—CYP3A4—central nervous system—systemic lupus erythematosus	0.00016	0.00328	CbGeAlD
Tacrolimus—ABCB1—lymphoid tissue—systemic lupus erythematosus	0.000154	0.00316	CbGeAlD
Tacrolimus—ABCB1—bone marrow—systemic lupus erythematosus	0.00014	0.00287	CbGeAlD
Tacrolimus—ABCB1—lung—systemic lupus erythematosus	0.000127	0.0026	CbGeAlD
Tacrolimus—ABCB1—nervous system—systemic lupus erythematosus	0.000118	0.00241	CbGeAlD
Tacrolimus—ABCB1—central nervous system—systemic lupus erythematosus	0.000113	0.00232	CbGeAlD
Tacrolimus—Oedema—Dexamethasone—systemic lupus erythematosus	2.83e-05	0.000156	CcSEcCtD
Tacrolimus—Oedema—Betamethasone—systemic lupus erythematosus	2.83e-05	0.000156	CcSEcCtD
Tacrolimus—Anaphylactic shock—Dexamethasone—systemic lupus erythematosus	2.83e-05	0.000156	CcSEcCtD
Tacrolimus—Anaphylactic shock—Betamethasone—systemic lupus erythematosus	2.83e-05	0.000156	CcSEcCtD
Tacrolimus—Insomnia—Triamcinolone—systemic lupus erythematosus	2.82e-05	0.000155	CcSEcCtD
Tacrolimus—Insomnia—Methylprednisolone—systemic lupus erythematosus	2.81e-05	0.000155	CcSEcCtD
Tacrolimus—Infection—Dexamethasone—systemic lupus erythematosus	2.81e-05	0.000155	CcSEcCtD
Tacrolimus—Infection—Betamethasone—systemic lupus erythematosus	2.81e-05	0.000155	CcSEcCtD
Tacrolimus—Ill-defined disorder—Prednisone—systemic lupus erythematosus	2.8e-05	0.000154	CcSEcCtD
Tacrolimus—Paraesthesia—Triamcinolone—systemic lupus erythematosus	2.8e-05	0.000154	CcSEcCtD
Tacrolimus—Feeling abnormal—Prednisolone—systemic lupus erythematosus	2.79e-05	0.000154	CcSEcCtD
Tacrolimus—Paraesthesia—Methylprednisolone—systemic lupus erythematosus	2.79e-05	0.000154	CcSEcCtD
Tacrolimus—Visual impairment—Methotrexate—systemic lupus erythematosus	2.79e-05	0.000154	CcSEcCtD
Tacrolimus—Anaemia—Prednisone—systemic lupus erythematosus	2.79e-05	0.000153	CcSEcCtD
Tacrolimus—Shock—Betamethasone—systemic lupus erythematosus	2.78e-05	0.000153	CcSEcCtD
Tacrolimus—Shock—Dexamethasone—systemic lupus erythematosus	2.78e-05	0.000153	CcSEcCtD
Tacrolimus—Dyspnoea—Triamcinolone—systemic lupus erythematosus	2.78e-05	0.000153	CcSEcCtD
Tacrolimus—Nervous system disorder—Dexamethasone—systemic lupus erythematosus	2.77e-05	0.000153	CcSEcCtD
Tacrolimus—Nervous system disorder—Betamethasone—systemic lupus erythematosus	2.77e-05	0.000153	CcSEcCtD
Tacrolimus—Agitation—Prednisone—systemic lupus erythematosus	2.77e-05	0.000153	CcSEcCtD
Tacrolimus—Thrombocytopenia—Betamethasone—systemic lupus erythematosus	2.77e-05	0.000152	CcSEcCtD
Tacrolimus—Thrombocytopenia—Dexamethasone—systemic lupus erythematosus	2.77e-05	0.000152	CcSEcCtD
Tacrolimus—Tachycardia—Betamethasone—systemic lupus erythematosus	2.76e-05	0.000152	CcSEcCtD
Tacrolimus—Tachycardia—Dexamethasone—systemic lupus erythematosus	2.76e-05	0.000152	CcSEcCtD
Tacrolimus—Hypersensitivity—Cyclosporine—systemic lupus erythematosus	2.74e-05	0.000151	CcSEcCtD
Tacrolimus—Dyspepsia—Triamcinolone—systemic lupus erythematosus	2.74e-05	0.000151	CcSEcCtD
Tacrolimus—Erythema multiforme—Methotrexate—systemic lupus erythematosus	2.74e-05	0.000151	CcSEcCtD
Tacrolimus—Dyspepsia—Methylprednisolone—systemic lupus erythematosus	2.74e-05	0.000151	CcSEcCtD
Tacrolimus—Hyperhidrosis—Dexamethasone—systemic lupus erythematosus	2.73e-05	0.00015	CcSEcCtD
Tacrolimus—Hyperhidrosis—Betamethasone—systemic lupus erythematosus	2.73e-05	0.00015	CcSEcCtD
Tacrolimus—Feeling abnormal—Hydrocortisone—systemic lupus erythematosus	2.73e-05	0.00015	CcSEcCtD
Tacrolimus—Malaise—Prednisone—systemic lupus erythematosus	2.72e-05	0.00015	CcSEcCtD
Tacrolimus—Vertigo—Prednisone—systemic lupus erythematosus	2.71e-05	0.000149	CcSEcCtD
Tacrolimus—Eye disorder—Methotrexate—systemic lupus erythematosus	2.71e-05	0.000149	CcSEcCtD
Tacrolimus—Gastrointestinal pain—Hydrocortisone—systemic lupus erythematosus	2.71e-05	0.000149	CcSEcCtD
Tacrolimus—Syncope—Prednisone—systemic lupus erythematosus	2.7e-05	0.000149	CcSEcCtD
Tacrolimus—Tinnitus—Methotrexate—systemic lupus erythematosus	2.7e-05	0.000149	CcSEcCtD
Tacrolimus—Anorexia—Dexamethasone—systemic lupus erythematosus	2.69e-05	0.000148	CcSEcCtD
Tacrolimus—Anorexia—Betamethasone—systemic lupus erythematosus	2.69e-05	0.000148	CcSEcCtD
Tacrolimus—Urticaria—Prednisolone—systemic lupus erythematosus	2.69e-05	0.000148	CcSEcCtD
Tacrolimus—Cardiac disorder—Methotrexate—systemic lupus erythematosus	2.69e-05	0.000148	CcSEcCtD
Tacrolimus—Fatigue—Triamcinolone—systemic lupus erythematosus	2.69e-05	0.000148	CcSEcCtD
Tacrolimus—Fatigue—Methylprednisolone—systemic lupus erythematosus	2.68e-05	0.000147	CcSEcCtD
Tacrolimus—Hypersensitivity—Mycophenolate mofetil—systemic lupus erythematosus	2.68e-05	0.000147	CcSEcCtD
Tacrolimus—Asthenia—Cyclosporine—systemic lupus erythematosus	2.67e-05	0.000147	CcSEcCtD
Tacrolimus—Pain—Triamcinolone—systemic lupus erythematosus	2.66e-05	0.000147	CcSEcCtD
Tacrolimus—Loss of consciousness—Prednisone—systemic lupus erythematosus	2.65e-05	0.000146	CcSEcCtD
Tacrolimus—Hypotension—Dexamethasone—systemic lupus erythematosus	2.64e-05	0.000145	CcSEcCtD
Tacrolimus—Hypotension—Betamethasone—systemic lupus erythematosus	2.64e-05	0.000145	CcSEcCtD
Tacrolimus—Pruritus—Cyclosporine—systemic lupus erythematosus	2.63e-05	0.000145	CcSEcCtD
Tacrolimus—Urticaria—Hydrocortisone—systemic lupus erythematosus	2.63e-05	0.000145	CcSEcCtD
Tacrolimus—Angiopathy—Methotrexate—systemic lupus erythematosus	2.63e-05	0.000145	CcSEcCtD
Tacrolimus—Immune system disorder—Methotrexate—systemic lupus erythematosus	2.62e-05	0.000144	CcSEcCtD
Tacrolimus—Abdominal pain—Hydrocortisone—systemic lupus erythematosus	2.62e-05	0.000144	CcSEcCtD
Tacrolimus—Body temperature increased—Hydrocortisone—systemic lupus erythematosus	2.62e-05	0.000144	CcSEcCtD
Tacrolimus—Convulsion—Prednisone—systemic lupus erythematosus	2.61e-05	0.000144	CcSEcCtD
Tacrolimus—Mediastinal disorder—Methotrexate—systemic lupus erythematosus	2.61e-05	0.000144	CcSEcCtD
Tacrolimus—Asthenia—Mycophenolate mofetil—systemic lupus erythematosus	2.61e-05	0.000143	CcSEcCtD
Tacrolimus—Hypertension—Prednisone—systemic lupus erythematosus	2.6e-05	0.000143	CcSEcCtD
Tacrolimus—Chills—Methotrexate—systemic lupus erythematosus	2.6e-05	0.000143	CcSEcCtD
Tacrolimus—Musculoskeletal discomfort—Betamethasone—systemic lupus erythematosus	2.58e-05	0.000142	CcSEcCtD
Tacrolimus—Musculoskeletal discomfort—Dexamethasone—systemic lupus erythematosus	2.58e-05	0.000142	CcSEcCtD
Tacrolimus—Pruritus—Mycophenolate mofetil—systemic lupus erythematosus	2.57e-05	0.000141	CcSEcCtD
Tacrolimus—Arthralgia—Prednisone—systemic lupus erythematosus	2.57e-05	0.000141	CcSEcCtD
Tacrolimus—Myalgia—Prednisone—systemic lupus erythematosus	2.57e-05	0.000141	CcSEcCtD
Tacrolimus—Feeling abnormal—Triamcinolone—systemic lupus erythematosus	2.57e-05	0.000141	CcSEcCtD
Tacrolimus—Feeling abnormal—Methylprednisolone—systemic lupus erythematosus	2.56e-05	0.000141	CcSEcCtD
Tacrolimus—Anxiety—Prednisone—systemic lupus erythematosus	2.56e-05	0.000141	CcSEcCtD
Tacrolimus—Alopecia—Methotrexate—systemic lupus erythematosus	2.56e-05	0.000141	CcSEcCtD
Tacrolimus—Insomnia—Betamethasone—systemic lupus erythematosus	2.56e-05	0.000141	CcSEcCtD
Tacrolimus—Insomnia—Dexamethasone—systemic lupus erythematosus	2.56e-05	0.000141	CcSEcCtD
Tacrolimus—Unspecified disorder of skin and subcutaneous tissue—Prednisone—systemic lupus erythematosus	2.55e-05	0.00014	CcSEcCtD
Tacrolimus—Diarrhoea—Cyclosporine—systemic lupus erythematosus	2.55e-05	0.00014	CcSEcCtD
Tacrolimus—Gastrointestinal pain—Methylprednisolone—systemic lupus erythematosus	2.54e-05	0.00014	CcSEcCtD
Tacrolimus—Paraesthesia—Betamethasone—systemic lupus erythematosus	2.54e-05	0.00014	CcSEcCtD
Tacrolimus—Paraesthesia—Dexamethasone—systemic lupus erythematosus	2.54e-05	0.00014	CcSEcCtD
Tacrolimus—Discomfort—Prednisone—systemic lupus erythematosus	2.54e-05	0.00014	CcSEcCtD
Tacrolimus—Mental disorder—Methotrexate—systemic lupus erythematosus	2.54e-05	0.00014	CcSEcCtD
Tacrolimus—Erythema—Methotrexate—systemic lupus erythematosus	2.52e-05	0.000139	CcSEcCtD
Tacrolimus—Malnutrition—Methotrexate—systemic lupus erythematosus	2.52e-05	0.000139	CcSEcCtD
Tacrolimus—Hypersensitivity—Prednisolone—systemic lupus erythematosus	2.5e-05	0.000137	CcSEcCtD
Tacrolimus—Dyspepsia—Dexamethasone—systemic lupus erythematosus	2.49e-05	0.000137	CcSEcCtD
Tacrolimus—Dyspepsia—Betamethasone—systemic lupus erythematosus	2.49e-05	0.000137	CcSEcCtD
Tacrolimus—Diarrhoea—Mycophenolate mofetil—systemic lupus erythematosus	2.48e-05	0.000137	CcSEcCtD
Tacrolimus—Urticaria—Triamcinolone—systemic lupus erythematosus	2.47e-05	0.000136	CcSEcCtD
Tacrolimus—Urticaria—Methylprednisolone—systemic lupus erythematosus	2.47e-05	0.000136	CcSEcCtD
Tacrolimus—Dysgeusia—Methotrexate—systemic lupus erythematosus	2.47e-05	0.000136	CcSEcCtD
Tacrolimus—Body temperature increased—Triamcinolone—systemic lupus erythematosus	2.46e-05	0.000136	CcSEcCtD
Tacrolimus—Dizziness—Cyclosporine—systemic lupus erythematosus	2.46e-05	0.000135	CcSEcCtD
Tacrolimus—Anaphylactic shock—Prednisone—systemic lupus erythematosus	2.46e-05	0.000135	CcSEcCtD
Tacrolimus—Oedema—Prednisone—systemic lupus erythematosus	2.46e-05	0.000135	CcSEcCtD
Tacrolimus—Abdominal pain—Methylprednisolone—systemic lupus erythematosus	2.46e-05	0.000135	CcSEcCtD
Tacrolimus—Decreased appetite—Dexamethasone—systemic lupus erythematosus	2.46e-05	0.000135	CcSEcCtD
Tacrolimus—Decreased appetite—Betamethasone—systemic lupus erythematosus	2.46e-05	0.000135	CcSEcCtD
Tacrolimus—Infection—Prednisone—systemic lupus erythematosus	2.45e-05	0.000135	CcSEcCtD
Tacrolimus—Gastrointestinal disorder—Dexamethasone—systemic lupus erythematosus	2.44e-05	0.000134	CcSEcCtD
Tacrolimus—Gastrointestinal disorder—Betamethasone—systemic lupus erythematosus	2.44e-05	0.000134	CcSEcCtD
Tacrolimus—Back pain—Methotrexate—systemic lupus erythematosus	2.44e-05	0.000134	CcSEcCtD
Tacrolimus—Hypersensitivity—Hydrocortisone—systemic lupus erythematosus	2.44e-05	0.000134	CcSEcCtD
Tacrolimus—Fatigue—Dexamethasone—systemic lupus erythematosus	2.44e-05	0.000134	CcSEcCtD
Tacrolimus—Fatigue—Betamethasone—systemic lupus erythematosus	2.44e-05	0.000134	CcSEcCtD
Tacrolimus—Shock—Prednisone—systemic lupus erythematosus	2.42e-05	0.000133	CcSEcCtD
Tacrolimus—Pain—Betamethasone—systemic lupus erythematosus	2.42e-05	0.000133	CcSEcCtD
Tacrolimus—Pain—Dexamethasone—systemic lupus erythematosus	2.42e-05	0.000133	CcSEcCtD
Tacrolimus—Nervous system disorder—Prednisone—systemic lupus erythematosus	2.41e-05	0.000133	CcSEcCtD
Tacrolimus—Tachycardia—Prednisone—systemic lupus erythematosus	2.4e-05	0.000132	CcSEcCtD
Tacrolimus—Dizziness—Mycophenolate mofetil—systemic lupus erythematosus	2.4e-05	0.000132	CcSEcCtD
Tacrolimus—Skin disorder—Prednisone—systemic lupus erythematosus	2.39e-05	0.000132	CcSEcCtD
Tacrolimus—Hyperhidrosis—Prednisone—systemic lupus erythematosus	2.38e-05	0.000131	CcSEcCtD
Tacrolimus—Vision blurred—Methotrexate—systemic lupus erythematosus	2.38e-05	0.000131	CcSEcCtD
Tacrolimus—Asthenia—Hydrocortisone—systemic lupus erythematosus	2.37e-05	0.000131	CcSEcCtD
Tacrolimus—Vomiting—Cyclosporine—systemic lupus erythematosus	2.37e-05	0.00013	CcSEcCtD
Tacrolimus—Rash—Cyclosporine—systemic lupus erythematosus	2.35e-05	0.000129	CcSEcCtD
Tacrolimus—Anorexia—Prednisone—systemic lupus erythematosus	2.35e-05	0.000129	CcSEcCtD
Tacrolimus—Dermatitis—Cyclosporine—systemic lupus erythematosus	2.35e-05	0.000129	CcSEcCtD
Tacrolimus—Pruritus—Hydrocortisone—systemic lupus erythematosus	2.34e-05	0.000129	CcSEcCtD
Tacrolimus—Ill-defined disorder—Methotrexate—systemic lupus erythematosus	2.34e-05	0.000129	CcSEcCtD
Tacrolimus—Headache—Cyclosporine—systemic lupus erythematosus	2.33e-05	0.000128	CcSEcCtD
Tacrolimus—Anaemia—Methotrexate—systemic lupus erythematosus	2.33e-05	0.000128	CcSEcCtD
Tacrolimus—Feeling abnormal—Betamethasone—systemic lupus erythematosus	2.33e-05	0.000128	CcSEcCtD
Tacrolimus—Feeling abnormal—Dexamethasone—systemic lupus erythematosus	2.33e-05	0.000128	CcSEcCtD
Tacrolimus—Gastrointestinal pain—Betamethasone—systemic lupus erythematosus	2.31e-05	0.000127	CcSEcCtD
Tacrolimus—Gastrointestinal pain—Dexamethasone—systemic lupus erythematosus	2.31e-05	0.000127	CcSEcCtD
Tacrolimus—Vomiting—Mycophenolate mofetil—systemic lupus erythematosus	2.31e-05	0.000127	CcSEcCtD
Tacrolimus—Hypersensitivity—Triamcinolone—systemic lupus erythematosus	2.3e-05	0.000126	CcSEcCtD
Tacrolimus—Hypersensitivity—Methylprednisolone—systemic lupus erythematosus	2.29e-05	0.000126	CcSEcCtD
Tacrolimus—Rash—Mycophenolate mofetil—systemic lupus erythematosus	2.29e-05	0.000126	CcSEcCtD
Tacrolimus—Dermatitis—Mycophenolate mofetil—systemic lupus erythematosus	2.29e-05	0.000126	CcSEcCtD
Tacrolimus—Headache—Mycophenolate mofetil—systemic lupus erythematosus	2.28e-05	0.000125	CcSEcCtD
Tacrolimus—Malaise—Methotrexate—systemic lupus erythematosus	2.27e-05	0.000125	CcSEcCtD
Tacrolimus—Vertigo—Methotrexate—systemic lupus erythematosus	2.26e-05	0.000125	CcSEcCtD
Tacrolimus—Diarrhoea—Hydrocortisone—systemic lupus erythematosus	2.26e-05	0.000125	CcSEcCtD
Tacrolimus—Leukopenia—Methotrexate—systemic lupus erythematosus	2.26e-05	0.000124	CcSEcCtD
Tacrolimus—Urticaria—Betamethasone—systemic lupus erythematosus	2.25e-05	0.000124	CcSEcCtD
Tacrolimus—Urticaria—Dexamethasone—systemic lupus erythematosus	2.25e-05	0.000124	CcSEcCtD
Tacrolimus—Musculoskeletal discomfort—Prednisone—systemic lupus erythematosus	2.24e-05	0.000123	CcSEcCtD
Tacrolimus—Dizziness—Prednisolone—systemic lupus erythematosus	2.24e-05	0.000123	CcSEcCtD
Tacrolimus—Asthenia—Triamcinolone—systemic lupus erythematosus	2.24e-05	0.000123	CcSEcCtD
Tacrolimus—Body temperature increased—Dexamethasone—systemic lupus erythematosus	2.23e-05	0.000123	CcSEcCtD
Tacrolimus—Body temperature increased—Betamethasone—systemic lupus erythematosus	2.23e-05	0.000123	CcSEcCtD
Tacrolimus—Abdominal pain—Dexamethasone—systemic lupus erythematosus	2.23e-05	0.000123	CcSEcCtD
Tacrolimus—Abdominal pain—Betamethasone—systemic lupus erythematosus	2.23e-05	0.000123	CcSEcCtD
Tacrolimus—Asthenia—Methylprednisolone—systemic lupus erythematosus	2.23e-05	0.000123	CcSEcCtD
Tacrolimus—Insomnia—Prednisone—systemic lupus erythematosus	2.23e-05	0.000123	CcSEcCtD
Tacrolimus—Nausea—Cyclosporine—systemic lupus erythematosus	2.21e-05	0.000122	CcSEcCtD
Tacrolimus—Paraesthesia—Prednisone—systemic lupus erythematosus	2.21e-05	0.000122	CcSEcCtD
Tacrolimus—Pruritus—Triamcinolone—systemic lupus erythematosus	2.2e-05	0.000121	CcSEcCtD
Tacrolimus—Cough—Methotrexate—systemic lupus erythematosus	2.2e-05	0.000121	CcSEcCtD
Tacrolimus—Pruritus—Methylprednisolone—systemic lupus erythematosus	2.2e-05	0.000121	CcSEcCtD
Tacrolimus—Dizziness—Hydrocortisone—systemic lupus erythematosus	2.19e-05	0.00012	CcSEcCtD
Tacrolimus—Convulsion—Methotrexate—systemic lupus erythematosus	2.18e-05	0.00012	CcSEcCtD
Tacrolimus—Dyspepsia—Prednisone—systemic lupus erythematosus	2.17e-05	0.000119	CcSEcCtD
Tacrolimus—Nausea—Mycophenolate mofetil—systemic lupus erythematosus	2.16e-05	0.000119	CcSEcCtD
Tacrolimus—Myalgia—Methotrexate—systemic lupus erythematosus	2.15e-05	0.000118	CcSEcCtD
Tacrolimus—Arthralgia—Methotrexate—systemic lupus erythematosus	2.15e-05	0.000118	CcSEcCtD
Tacrolimus—Chest pain—Methotrexate—systemic lupus erythematosus	2.15e-05	0.000118	CcSEcCtD
Tacrolimus—Decreased appetite—Prednisone—systemic lupus erythematosus	2.14e-05	0.000118	CcSEcCtD
Tacrolimus—Rash—Prednisolone—systemic lupus erythematosus	2.14e-05	0.000118	CcSEcCtD
Tacrolimus—Dermatitis—Prednisolone—systemic lupus erythematosus	2.13e-05	0.000117	CcSEcCtD
Tacrolimus—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—systemic lupus erythematosus	2.13e-05	0.000117	CcSEcCtD
Tacrolimus—Diarrhoea—Methylprednisolone—systemic lupus erythematosus	2.13e-05	0.000117	CcSEcCtD
Tacrolimus—Fatigue—Prednisone—systemic lupus erythematosus	2.12e-05	0.000117	CcSEcCtD
Tacrolimus—Headache—Prednisolone—systemic lupus erythematosus	2.12e-05	0.000117	CcSEcCtD
Tacrolimus—Discomfort—Methotrexate—systemic lupus erythematosus	2.12e-05	0.000117	CcSEcCtD
Tacrolimus—Constipation—Prednisone—systemic lupus erythematosus	2.11e-05	0.000116	CcSEcCtD
Tacrolimus—Vomiting—Hydrocortisone—systemic lupus erythematosus	2.1e-05	0.000116	CcSEcCtD
Tacrolimus—Rash—Hydrocortisone—systemic lupus erythematosus	2.09e-05	0.000115	CcSEcCtD
Tacrolimus—Dermatitis—Hydrocortisone—systemic lupus erythematosus	2.08e-05	0.000115	CcSEcCtD
Tacrolimus—Confusional state—Methotrexate—systemic lupus erythematosus	2.07e-05	0.000114	CcSEcCtD
Tacrolimus—Headache—Hydrocortisone—systemic lupus erythematosus	2.07e-05	0.000114	CcSEcCtD
Tacrolimus—Dizziness—Triamcinolone—systemic lupus erythematosus	2.06e-05	0.000113	CcSEcCtD
Tacrolimus—Anaphylactic shock—Methotrexate—systemic lupus erythematosus	2.06e-05	0.000113	CcSEcCtD
Tacrolimus—Dizziness—Methylprednisolone—systemic lupus erythematosus	2.06e-05	0.000113	CcSEcCtD
Tacrolimus—PPP3CA—Signaling by GPCR—TYK2—systemic lupus erythematosus	2.05e-05	0.000282	CbGpPWpGaD
Tacrolimus—PPP3CA—Disease—CD80—systemic lupus erythematosus	2.05e-05	0.000282	CbGpPWpGaD
Tacrolimus—Infection—Methotrexate—systemic lupus erythematosus	2.04e-05	0.000112	CcSEcCtD
Tacrolimus—MTOR—Immune System—BLK—systemic lupus erythematosus	2.04e-05	0.000281	CbGpPWpGaD
Tacrolimus—FKBP1A—Disease—JAK1—systemic lupus erythematosus	2.04e-05	0.00028	CbGpPWpGaD
Tacrolimus—MTOR—Disease—CD247—systemic lupus erythematosus	2.04e-05	0.00028	CbGpPWpGaD
Tacrolimus—Feeling abnormal—Prednisone—systemic lupus erythematosus	2.03e-05	0.000112	CcSEcCtD
Tacrolimus—Asthenia—Dexamethasone—systemic lupus erythematosus	2.03e-05	0.000112	CcSEcCtD
Tacrolimus—Asthenia—Betamethasone—systemic lupus erythematosus	2.03e-05	0.000112	CcSEcCtD
Tacrolimus—MTOR—Downstream signaling of activated FGFR—IL6—systemic lupus erythematosus	2.03e-05	0.000279	CbGpPWpGaD
Tacrolimus—Nervous system disorder—Methotrexate—systemic lupus erythematosus	2.02e-05	0.000111	CcSEcCtD
Tacrolimus—Thrombocytopenia—Methotrexate—systemic lupus erythematosus	2.01e-05	0.000111	CcSEcCtD
Tacrolimus—Gastrointestinal pain—Prednisone—systemic lupus erythematosus	2.01e-05	0.000111	CcSEcCtD
Tacrolimus—Nausea—Prednisolone—systemic lupus erythematosus	2.01e-05	0.000111	CcSEcCtD
Tacrolimus—Pruritus—Dexamethasone—systemic lupus erythematosus	2e-05	0.00011	CcSEcCtD
Tacrolimus—Pruritus—Betamethasone—systemic lupus erythematosus	2e-05	0.00011	CcSEcCtD
Tacrolimus—ALB—Hemostasis—LYN—systemic lupus erythematosus	2e-05	0.000275	CbGpPWpGaD
Tacrolimus—Skin disorder—Methotrexate—systemic lupus erythematosus	2e-05	0.00011	CcSEcCtD
Tacrolimus—MTOR—Signaling by ERBB4—IL6—systemic lupus erythematosus	1.99e-05	0.000274	CbGpPWpGaD
Tacrolimus—Hyperhidrosis—Methotrexate—systemic lupus erythematosus	1.99e-05	0.000109	CcSEcCtD
Tacrolimus—MTOR—Disease—NCF2—systemic lupus erythematosus	1.98e-05	0.000272	CbGpPWpGaD
Tacrolimus—Vomiting—Triamcinolone—systemic lupus erythematosus	1.98e-05	0.000109	CcSEcCtD
Tacrolimus—Vomiting—Methylprednisolone—systemic lupus erythematosus	1.98e-05	0.000109	CcSEcCtD
Tacrolimus—MTOR—Innate Immune System—C3—systemic lupus erythematosus	1.97e-05	0.000271	CbGpPWpGaD
Tacrolimus—FKBP1A—Signaling Pathways—CXCL12—systemic lupus erythematosus	1.97e-05	0.000271	CbGpPWpGaD
Tacrolimus—Nausea—Hydrocortisone—systemic lupus erythematosus	1.97e-05	0.000108	CcSEcCtD
Tacrolimus—Rash—Triamcinolone—systemic lupus erythematosus	1.96e-05	0.000108	CcSEcCtD
Tacrolimus—Dermatitis—Triamcinolone—systemic lupus erythematosus	1.96e-05	0.000108	CcSEcCtD
Tacrolimus—Anorexia—Methotrexate—systemic lupus erythematosus	1.96e-05	0.000108	CcSEcCtD
Tacrolimus—ALB—Hemostasis—SH2B3—systemic lupus erythematosus	1.96e-05	0.000269	CbGpPWpGaD
Tacrolimus—Rash—Methylprednisolone—systemic lupus erythematosus	1.96e-05	0.000108	CcSEcCtD
Tacrolimus—Dermatitis—Methylprednisolone—systemic lupus erythematosus	1.96e-05	0.000108	CcSEcCtD
Tacrolimus—MTOR—Cellular responses to stress—EP300—systemic lupus erythematosus	1.96e-05	0.000269	CbGpPWpGaD
Tacrolimus—Urticaria—Prednisone—systemic lupus erythematosus	1.96e-05	0.000108	CcSEcCtD
Tacrolimus—Headache—Triamcinolone—systemic lupus erythematosus	1.95e-05	0.000107	CcSEcCtD
Tacrolimus—Headache—Methylprednisolone—systemic lupus erythematosus	1.95e-05	0.000107	CcSEcCtD
Tacrolimus—Body temperature increased—Prednisone—systemic lupus erythematosus	1.95e-05	0.000107	CcSEcCtD
Tacrolimus—Abdominal pain—Prednisone—systemic lupus erythematosus	1.95e-05	0.000107	CcSEcCtD
Tacrolimus—FKBP1A—Signaling Pathways—JUNB—systemic lupus erythematosus	1.94e-05	0.000266	CbGpPWpGaD
Tacrolimus—Diarrhoea—Betamethasone—systemic lupus erythematosus	1.93e-05	0.000106	CcSEcCtD
Tacrolimus—Diarrhoea—Dexamethasone—systemic lupus erythematosus	1.93e-05	0.000106	CcSEcCtD
Tacrolimus—FKBP1A—Disease—CCR5—systemic lupus erythematosus	1.93e-05	0.000265	CbGpPWpGaD
Tacrolimus—MTOR—Signaling by NGF—CDKN1A—systemic lupus erythematosus	1.93e-05	0.000265	CbGpPWpGaD
Tacrolimus—ABCB1—Allograft Rejection—TGFB1—systemic lupus erythematosus	1.92e-05	0.000264	CbGpPWpGaD
Tacrolimus—Hypotension—Methotrexate—systemic lupus erythematosus	1.92e-05	0.000106	CcSEcCtD
Tacrolimus—ALB—Folate Metabolism—IL6—systemic lupus erythematosus	1.91e-05	0.000263	CbGpPWpGaD
Tacrolimus—MTOR—Downstream signal transduction—IL6—systemic lupus erythematosus	1.9e-05	0.000262	CbGpPWpGaD
Tacrolimus—MTOR—Adaptive Immune System—C3—systemic lupus erythematosus	1.9e-05	0.000261	CbGpPWpGaD
Tacrolimus—MTOR—Signaling by FGFR—IL6—systemic lupus erythematosus	1.89e-05	0.00026	CbGpPWpGaD
Tacrolimus—MTOR—Signaling by ERBB2—IL6—systemic lupus erythematosus	1.89e-05	0.000259	CbGpPWpGaD
Tacrolimus—ALB—Selenium Micronutrient Network—TNF—systemic lupus erythematosus	1.88e-05	0.000258	CbGpPWpGaD
Tacrolimus—MTOR—Innate Immune System—CRP—systemic lupus erythematosus	1.88e-05	0.000258	CbGpPWpGaD
Tacrolimus—MTOR—DAP12 signaling—IL6—systemic lupus erythematosus	1.88e-05	0.000258	CbGpPWpGaD
Tacrolimus—Musculoskeletal discomfort—Methotrexate—systemic lupus erythematosus	1.87e-05	0.000103	CcSEcCtD
Tacrolimus—PPP3CA—Immune System—TYK2—systemic lupus erythematosus	1.87e-05	0.000257	CbGpPWpGaD
Tacrolimus—Dizziness—Dexamethasone—systemic lupus erythematosus	1.87e-05	0.000103	CcSEcCtD
Tacrolimus—Dizziness—Betamethasone—systemic lupus erythematosus	1.87e-05	0.000103	CcSEcCtD
Tacrolimus—Insomnia—Methotrexate—systemic lupus erythematosus	1.86e-05	0.000102	CcSEcCtD
Tacrolimus—MTOR—Cellular responses to stress—VEGFA—systemic lupus erythematosus	1.85e-05	0.000255	CbGpPWpGaD
Tacrolimus—Nausea—Triamcinolone—systemic lupus erythematosus	1.85e-05	0.000102	CcSEcCtD
Tacrolimus—Paraesthesia—Methotrexate—systemic lupus erythematosus	1.85e-05	0.000102	CcSEcCtD
Tacrolimus—Nausea—Methylprednisolone—systemic lupus erythematosus	1.85e-05	0.000102	CcSEcCtD
Tacrolimus—PPP3CA—Signaling Pathways—JAK1—systemic lupus erythematosus	1.84e-05	0.000253	CbGpPWpGaD
Tacrolimus—FKBP1A—Signaling Pathways—RASGRP1—systemic lupus erythematosus	1.84e-05	0.000253	CbGpPWpGaD
Tacrolimus—ALB—Platelet activation, signaling and aggregation—F2—systemic lupus erythematosus	1.83e-05	0.000252	CbGpPWpGaD
Tacrolimus—Dyspnoea—Methotrexate—systemic lupus erythematosus	1.83e-05	0.000101	CcSEcCtD
Tacrolimus—Somnolence—Methotrexate—systemic lupus erythematosus	1.83e-05	0.000101	CcSEcCtD
Tacrolimus—MTOR—Immune System—PTPRC—systemic lupus erythematosus	1.83e-05	0.000251	CbGpPWpGaD
Tacrolimus—MTOR—Immune System—IL1RN—systemic lupus erythematosus	1.82e-05	0.00025	CbGpPWpGaD
Tacrolimus—Hypersensitivity—Prednisone—systemic lupus erythematosus	1.81e-05	9.98e-05	CcSEcCtD
Tacrolimus—Dyspepsia—Methotrexate—systemic lupus erythematosus	1.81e-05	9.97e-05	CcSEcCtD
Tacrolimus—MTOR—Innate Immune System—TLR4—systemic lupus erythematosus	1.8e-05	0.000247	CbGpPWpGaD
Tacrolimus—Vomiting—Betamethasone—systemic lupus erythematosus	1.8e-05	9.89e-05	CcSEcCtD
Tacrolimus—Vomiting—Dexamethasone—systemic lupus erythematosus	1.8e-05	9.89e-05	CcSEcCtD
Tacrolimus—ABCB1—Allograft Rejection—TNF—systemic lupus erythematosus	1.8e-05	0.000247	CbGpPWpGaD
Tacrolimus—Decreased appetite—Methotrexate—systemic lupus erythematosus	1.79e-05	9.84e-05	CcSEcCtD
Tacrolimus—FKBP1A—Signaling Pathways—PRL—systemic lupus erythematosus	1.78e-05	0.000245	CbGpPWpGaD
Tacrolimus—Rash—Dexamethasone—systemic lupus erythematosus	1.78e-05	9.81e-05	CcSEcCtD
Tacrolimus—Rash—Betamethasone—systemic lupus erythematosus	1.78e-05	9.81e-05	CcSEcCtD
Tacrolimus—Dermatitis—Dexamethasone—systemic lupus erythematosus	1.78e-05	9.8e-05	CcSEcCtD
Tacrolimus—Dermatitis—Betamethasone—systemic lupus erythematosus	1.78e-05	9.8e-05	CcSEcCtD
Tacrolimus—Gastrointestinal disorder—Methotrexate—systemic lupus erythematosus	1.78e-05	9.78e-05	CcSEcCtD
Tacrolimus—Fatigue—Methotrexate—systemic lupus erythematosus	1.77e-05	9.76e-05	CcSEcCtD
Tacrolimus—Headache—Dexamethasone—systemic lupus erythematosus	1.77e-05	9.75e-05	CcSEcCtD
Tacrolimus—Headache—Betamethasone—systemic lupus erythematosus	1.77e-05	9.75e-05	CcSEcCtD
Tacrolimus—CYP3A4—Biological oxidations—RXRA—systemic lupus erythematosus	1.77e-05	0.000243	CbGpPWpGaD
Tacrolimus—Asthenia—Prednisone—systemic lupus erythematosus	1.77e-05	9.72e-05	CcSEcCtD
Tacrolimus—MTOR—Fc epsilon receptor (FCERI) signaling—IL6—systemic lupus erythematosus	1.77e-05	0.000243	CbGpPWpGaD
Tacrolimus—MTOR—Signaling by FGFR in disease—IL6—systemic lupus erythematosus	1.77e-05	0.000243	CbGpPWpGaD
Tacrolimus—MTOR—DAP12 interactions—IL6—systemic lupus erythematosus	1.77e-05	0.000243	CbGpPWpGaD
Tacrolimus—Pain—Methotrexate—systemic lupus erythematosus	1.76e-05	9.68e-05	CcSEcCtD
Tacrolimus—PPP3CA—Immune System—IFNG—systemic lupus erythematosus	1.75e-05	0.000241	CbGpPWpGaD
Tacrolimus—MTOR—Signaling by EGFR—IL6—systemic lupus erythematosus	1.75e-05	0.00024	CbGpPWpGaD
Tacrolimus—PPP3CA—Signaling Pathways—CCR5—systemic lupus erythematosus	1.74e-05	0.00024	CbGpPWpGaD
Tacrolimus—Pruritus—Prednisone—systemic lupus erythematosus	1.74e-05	9.59e-05	CcSEcCtD
Tacrolimus—MTOR—Signaling by EGFR in Cancer—IL6—systemic lupus erythematosus	1.73e-05	0.000238	CbGpPWpGaD
Tacrolimus—PPP3CA—Disease—TYK2—systemic lupus erythematosus	1.73e-05	0.000238	CbGpPWpGaD
Tacrolimus—MTOR—Adaptive Immune System—HLA-DRB1—systemic lupus erythematosus	1.73e-05	0.000237	CbGpPWpGaD
Tacrolimus—MTOR—Signaling by PDGF—IL6—systemic lupus erythematosus	1.73e-05	0.000237	CbGpPWpGaD
Tacrolimus—PPP3CA—Signaling Pathways—IL2RA—systemic lupus erythematosus	1.72e-05	0.000236	CbGpPWpGaD
Tacrolimus—PPP3CA—Signaling by GPCR—IL2—systemic lupus erythematosus	1.71e-05	0.000234	CbGpPWpGaD
Tacrolimus—PPP3CA—Signaling Pathways—C3—systemic lupus erythematosus	1.7e-05	0.000234	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—TLR9—systemic lupus erythematosus	1.7e-05	0.000234	CbGpPWpGaD
Tacrolimus—PPP3CA—Disease—NOS3—systemic lupus erythematosus	1.7e-05	0.000233	CbGpPWpGaD
Tacrolimus—MTOR—Immune System—CD40—systemic lupus erythematosus	1.7e-05	0.000233	CbGpPWpGaD
Tacrolimus—Feeling abnormal—Methotrexate—systemic lupus erythematosus	1.7e-05	9.33e-05	CcSEcCtD
Tacrolimus—PPP3CA—Immune System—CD4—systemic lupus erythematosus	1.69e-05	0.000233	CbGpPWpGaD
Tacrolimus—Diarrhoea—Prednisone—systemic lupus erythematosus	1.68e-05	9.27e-05	CcSEcCtD
Tacrolimus—Gastrointestinal pain—Methotrexate—systemic lupus erythematosus	1.68e-05	9.26e-05	CcSEcCtD
Tacrolimus—Nausea—Dexamethasone—systemic lupus erythematosus	1.68e-05	9.24e-05	CcSEcCtD
Tacrolimus—Nausea—Betamethasone—systemic lupus erythematosus	1.68e-05	9.24e-05	CcSEcCtD
Tacrolimus—MTOR—Immune System—CTLA4—systemic lupus erythematosus	1.67e-05	0.00023	CbGpPWpGaD
Tacrolimus—MTOR—Immune System—HMGB1—systemic lupus erythematosus	1.67e-05	0.00023	CbGpPWpGaD
Tacrolimus—MTOR—Innate Immune System—CD80—systemic lupus erythematosus	1.66e-05	0.000228	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—P2RY12—systemic lupus erythematosus	1.65e-05	0.000227	CbGpPWpGaD
Tacrolimus—MTOR—Immune System—IFNA1—systemic lupus erythematosus	1.64e-05	0.000226	CbGpPWpGaD
Tacrolimus—Urticaria—Methotrexate—systemic lupus erythematosus	1.63e-05	9e-05	CcSEcCtD
Tacrolimus—Dizziness—Prednisone—systemic lupus erythematosus	1.63e-05	8.96e-05	CcSEcCtD
Tacrolimus—Abdominal pain—Methotrexate—systemic lupus erythematosus	1.63e-05	8.95e-05	CcSEcCtD
Tacrolimus—Body temperature increased—Methotrexate—systemic lupus erythematosus	1.63e-05	8.95e-05	CcSEcCtD
Tacrolimus—CYP3A7—Metabolism—NAT2—systemic lupus erythematosus	1.61e-05	0.000221	CbGpPWpGaD
Tacrolimus—MTOR—Immune System—RASGRP1—systemic lupus erythematosus	1.6e-05	0.00022	CbGpPWpGaD
Tacrolimus—MTOR—Immune System—CD79A—systemic lupus erythematosus	1.6e-05	0.000219	CbGpPWpGaD
Tacrolimus—MTOR—Adaptive Immune System—CD80—systemic lupus erythematosus	1.6e-05	0.000219	CbGpPWpGaD
Tacrolimus—PPP3CA—Immune System—CDKN1B—systemic lupus erythematosus	1.59e-05	0.000219	CbGpPWpGaD
Tacrolimus—FKBP1A—Disease—CD80—systemic lupus erythematosus	1.59e-05	0.000218	CbGpPWpGaD
Tacrolimus—PPP3CA—Innate Immune System—IL6—systemic lupus erythematosus	1.57e-05	0.000216	CbGpPWpGaD
Tacrolimus—Vomiting—Prednisone—systemic lupus erythematosus	1.57e-05	8.61e-05	CcSEcCtD
Tacrolimus—PPP3CA—Disease—CD4—systemic lupus erythematosus	1.56e-05	0.000215	CbGpPWpGaD
Tacrolimus—MTOR—NGF signalling via TRKA from the plasma membrane—IL6—systemic lupus erythematosus	1.56e-05	0.000215	CbGpPWpGaD
Tacrolimus—PPP3CA—Immune System—IL2—systemic lupus erythematosus	1.56e-05	0.000214	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—HIST2H2AC—systemic lupus erythematosus	1.56e-05	0.000214	CbGpPWpGaD
Tacrolimus—MTOR—Disease—JUNB—systemic lupus erythematosus	1.56e-05	0.000214	CbGpPWpGaD
Tacrolimus—PPP3CA—Disease—PTGS2—systemic lupus erythematosus	1.55e-05	0.000213	CbGpPWpGaD
Tacrolimus—MTOR—Immune System—PRL—systemic lupus erythematosus	1.55e-05	0.000213	CbGpPWpGaD
Tacrolimus—Rash—Prednisone—systemic lupus erythematosus	1.55e-05	8.54e-05	CcSEcCtD
Tacrolimus—Dermatitis—Prednisone—systemic lupus erythematosus	1.55e-05	8.53e-05	CcSEcCtD
Tacrolimus—Headache—Prednisone—systemic lupus erythematosus	1.54e-05	8.49e-05	CcSEcCtD
Tacrolimus—ALB—Hemostasis—IFNA1—systemic lupus erythematosus	1.54e-05	0.000212	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—CSK—systemic lupus erythematosus	1.52e-05	0.000209	CbGpPWpGaD
Tacrolimus—ALB—Selenium Micronutrient Network—IL6—systemic lupus erythematosus	1.52e-05	0.000209	CbGpPWpGaD
Tacrolimus—Hypersensitivity—Methotrexate—systemic lupus erythematosus	1.52e-05	8.34e-05	CcSEcCtD
Tacrolimus—ALB—Hemostasis—RASGRP1—systemic lupus erythematosus	1.5e-05	0.000206	CbGpPWpGaD
Tacrolimus—PPP3CA—Signaling Pathways—F2—systemic lupus erythematosus	1.5e-05	0.000206	CbGpPWpGaD
Tacrolimus—Asthenia—Methotrexate—systemic lupus erythematosus	1.48e-05	8.12e-05	CcSEcCtD
Tacrolimus—MTOR—Immune System—HLA-DQA1—systemic lupus erythematosus	1.47e-05	0.000202	CbGpPWpGaD
Tacrolimus—PPP3CA—Disease—CDKN1B—systemic lupus erythematosus	1.47e-05	0.000202	CbGpPWpGaD
Tacrolimus—PPP3CA—Immune System—CDKN1A—systemic lupus erythematosus	1.47e-05	0.000202	CbGpPWpGaD
Tacrolimus—Nausea—Prednisone—systemic lupus erythematosus	1.46e-05	8.05e-05	CcSEcCtD
Tacrolimus—Pruritus—Methotrexate—systemic lupus erythematosus	1.46e-05	8.01e-05	CcSEcCtD
Tacrolimus—PPP3CA—Signaling Pathways—CD80—systemic lupus erythematosus	1.43e-05	0.000197	CbGpPWpGaD
Tacrolimus—MTOR—Disease—PRL—systemic lupus erythematosus	1.43e-05	0.000197	CbGpPWpGaD
Tacrolimus—FKBP1A—Signaling Pathways—JAK1—systemic lupus erythematosus	1.43e-05	0.000196	CbGpPWpGaD
Tacrolimus—Diarrhoea—Methotrexate—systemic lupus erythematosus	1.41e-05	7.75e-05	CcSEcCtD
Tacrolimus—MTOR—Innate Immune System—TYK2—systemic lupus erythematosus	1.4e-05	0.000193	CbGpPWpGaD
Tacrolimus—PPP3CA—Immune System—EP300—systemic lupus erythematosus	1.4e-05	0.000192	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—NCF2—systemic lupus erythematosus	1.39e-05	0.000191	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—LYN—systemic lupus erythematosus	1.38e-05	0.00019	CbGpPWpGaD
Tacrolimus—MTOR—Immune System—HLA-DQB1—systemic lupus erythematosus	1.38e-05	0.000189	CbGpPWpGaD
Tacrolimus—Dizziness—Methotrexate—systemic lupus erythematosus	1.36e-05	7.49e-05	CcSEcCtD
Tacrolimus—PPP3CA—Disease—CDKN1A—systemic lupus erythematosus	1.36e-05	0.000187	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—SH2B3—systemic lupus erythematosus	1.35e-05	0.000186	CbGpPWpGaD
Tacrolimus—FKBP1A—Signaling Pathways—CCR5—systemic lupus erythematosus	1.35e-05	0.000186	CbGpPWpGaD
Tacrolimus—FKBP1A—Disease—TYK2—systemic lupus erythematosus	1.34e-05	0.000184	CbGpPWpGaD
Tacrolimus—PPP3CA—Signaling Pathways—CCL2—systemic lupus erythematosus	1.33e-05	0.000183	CbGpPWpGaD
Tacrolimus—FKBP1A—Signaling Pathways—IL2RA—systemic lupus erythematosus	1.33e-05	0.000183	CbGpPWpGaD
Tacrolimus—FKBP1A—Signaling Pathways—C3—systemic lupus erythematosus	1.32e-05	0.000182	CbGpPWpGaD
Tacrolimus—FKBP1A—Disease—NOS3—systemic lupus erythematosus	1.32e-05	0.000181	CbGpPWpGaD
Tacrolimus—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—systemic lupus erythematosus	1.31e-05	0.00018	CbGpPWpGaD
Tacrolimus—Vomiting—Methotrexate—systemic lupus erythematosus	1.31e-05	7.2e-05	CcSEcCtD
Tacrolimus—MTOR—Immune System—IL18—systemic lupus erythematosus	1.31e-05	0.000179	CbGpPWpGaD
Tacrolimus—MTOR—Immune System—CD40LG—systemic lupus erythematosus	1.3e-05	0.000179	CbGpPWpGaD
Tacrolimus—Rash—Methotrexate—systemic lupus erythematosus	1.3e-05	7.14e-05	CcSEcCtD
Tacrolimus—Dermatitis—Methotrexate—systemic lupus erythematosus	1.3e-05	7.13e-05	CcSEcCtD
Tacrolimus—PPP3CA—Disease—EP300—systemic lupus erythematosus	1.29e-05	0.000177	CbGpPWpGaD
Tacrolimus—Headache—Methotrexate—systemic lupus erythematosus	1.29e-05	7.09e-05	CcSEcCtD
Tacrolimus—MTOR—Immune System—CD8A—systemic lupus erythematosus	1.29e-05	0.000177	CbGpPWpGaD
Tacrolimus—MTOR—Cellular responses to stress—IL6—systemic lupus erythematosus	1.28e-05	0.000176	CbGpPWpGaD
Tacrolimus—MTOR—Innate Immune System—CD4—systemic lupus erythematosus	1.27e-05	0.000174	CbGpPWpGaD
Tacrolimus—ALB—Metabolism of lipids and lipoproteins—RXRA—systemic lupus erythematosus	1.26e-05	0.000173	CbGpPWpGaD
Tacrolimus—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1B—systemic lupus erythematosus	1.24e-05	0.000171	CbGpPWpGaD
Tacrolimus—MTOR—Immune System—JAK1—systemic lupus erythematosus	1.24e-05	0.000171	CbGpPWpGaD
Tacrolimus—ALB—Platelet activation, signaling and aggregation—IL2—systemic lupus erythematosus	1.24e-05	0.00017	CbGpPWpGaD
Tacrolimus—Nausea—Methotrexate—systemic lupus erythematosus	1.22e-05	6.73e-05	CcSEcCtD
Tacrolimus—MTOR—Adaptive Immune System—CD4—systemic lupus erythematosus	1.22e-05	0.000167	CbGpPWpGaD
Tacrolimus—FKBP1A—Disease—CD4—systemic lupus erythematosus	1.21e-05	0.000167	CbGpPWpGaD
Tacrolimus—PPP3CA—Signaling Pathways—TYK2—systemic lupus erythematosus	1.21e-05	0.000166	CbGpPWpGaD
Tacrolimus—FKBP1A—Disease—PTGS2—systemic lupus erythematosus	1.2e-05	0.000165	CbGpPWpGaD
Tacrolimus—MTOR—Signaling by NGF—IL6—systemic lupus erythematosus	1.2e-05	0.000165	CbGpPWpGaD
Tacrolimus—ALB—Transmembrane transport of small molecules—RXRA—systemic lupus erythematosus	1.2e-05	0.000165	CbGpPWpGaD
Tacrolimus—MTOR—Innate Immune System—CDKN1B—systemic lupus erythematosus	1.19e-05	0.000164	CbGpPWpGaD
Tacrolimus—PPP3CA—Signaling Pathways—NOS3—systemic lupus erythematosus	1.19e-05	0.000163	CbGpPWpGaD
Tacrolimus—ALB—Hemostasis—JAK1—systemic lupus erythematosus	1.16e-05	0.00016	CbGpPWpGaD
Tacrolimus—CYP3A5—Metabolism—NAT2—systemic lupus erythematosus	1.16e-05	0.00016	CbGpPWpGaD
Tacrolimus—FKBP1A—Signaling Pathways—F2—systemic lupus erythematosus	1.16e-05	0.000159	CbGpPWpGaD
Tacrolimus—MTOR—Immune System—IL2RA—systemic lupus erythematosus	1.16e-05	0.000159	CbGpPWpGaD
Tacrolimus—MTOR—Immune System—C3—systemic lupus erythematosus	1.15e-05	0.000158	CbGpPWpGaD
Tacrolimus—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1A—systemic lupus erythematosus	1.15e-05	0.000158	CbGpPWpGaD
Tacrolimus—MTOR—Disease—JAK1—systemic lupus erythematosus	1.15e-05	0.000158	CbGpPWpGaD
Tacrolimus—MTOR—Adaptive Immune System—CDKN1B—systemic lupus erythematosus	1.15e-05	0.000157	CbGpPWpGaD
Tacrolimus—FKBP1A—Disease—CDKN1B—systemic lupus erythematosus	1.14e-05	0.000157	CbGpPWpGaD
Tacrolimus—PPP3CA—Disease—TGFB1—systemic lupus erythematosus	1.12e-05	0.000154	CbGpPWpGaD
Tacrolimus—FKBP1A—Signaling Pathways—CD80—systemic lupus erythematosus	1.11e-05	0.000153	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—CXCL12—systemic lupus erythematosus	1.11e-05	0.000153	CbGpPWpGaD
Tacrolimus—MTOR—Innate Immune System—CDKN1A—systemic lupus erythematosus	1.1e-05	0.000151	CbGpPWpGaD
Tacrolimus—MTOR—Immune System—CRP—systemic lupus erythematosus	1.09e-05	0.00015	CbGpPWpGaD
Tacrolimus—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—systemic lupus erythematosus	1.09e-05	0.00015	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—JUNB—systemic lupus erythematosus	1.09e-05	0.00015	CbGpPWpGaD
Tacrolimus—ALB—Hemostasis—IL2RA—systemic lupus erythematosus	1.09e-05	0.000149	CbGpPWpGaD
Tacrolimus—MTOR—Disease—CCR5—systemic lupus erythematosus	1.09e-05	0.000149	CbGpPWpGaD
Tacrolimus—MTOR—Adaptive Immune System—CDKN1A—systemic lupus erythematosus	1.06e-05	0.000145	CbGpPWpGaD
Tacrolimus—FKBP1A—Disease—CDKN1A—systemic lupus erythematosus	1.05e-05	0.000145	CbGpPWpGaD
Tacrolimus—ALB—Platelet activation, signaling and aggregation—VEGFA—systemic lupus erythematosus	1.05e-05	0.000144	CbGpPWpGaD
Tacrolimus—ABCB1—Transmembrane transport of small molecules—RXRA—systemic lupus erythematosus	1.05e-05	0.000144	CbGpPWpGaD
Tacrolimus—MTOR—Immune System—TLR4—systemic lupus erythematosus	1.05e-05	0.000144	CbGpPWpGaD
Tacrolimus—MTOR—Immune System—HLA-DRB1—systemic lupus erythematosus	1.05e-05	0.000144	CbGpPWpGaD
Tacrolimus—MTOR—Innate Immune System—EP300—systemic lupus erythematosus	1.05e-05	0.000144	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—RASGRP1—systemic lupus erythematosus	1.03e-05	0.000142	CbGpPWpGaD
Tacrolimus—FKBP1A—Signaling Pathways—CCL2—systemic lupus erythematosus	1.03e-05	0.000142	CbGpPWpGaD
Tacrolimus—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—systemic lupus erythematosus	1.03e-05	0.000142	CbGpPWpGaD
Tacrolimus—PPP3CA—Signaling Pathways—CDKN1B—systemic lupus erythematosus	1.03e-05	0.000142	CbGpPWpGaD
Tacrolimus—PPP3CA—Signaling Pathways—IL2—systemic lupus erythematosus	1.01e-05	0.000139	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—PRL—systemic lupus erythematosus	1e-05	0.000138	CbGpPWpGaD
Tacrolimus—PPP3CA—Signaling by GPCR—IL6—systemic lupus erythematosus	1e-05	0.000138	CbGpPWpGaD
Tacrolimus—FKBP1A—Disease—EP300—systemic lupus erythematosus	1e-05	0.000138	CbGpPWpGaD
Tacrolimus—ALB—Metabolism—NAT2—systemic lupus erythematosus	1e-05	0.000138	CbGpPWpGaD
Tacrolimus—MTOR—Immune System—CD80—systemic lupus erythematosus	9.68e-06	0.000133	CbGpPWpGaD
Tacrolimus—ALB—Platelet activation, signaling and aggregation—TGFB1—systemic lupus erythematosus	9.64e-06	0.000132	CbGpPWpGaD
Tacrolimus—PPP3CA—Signaling Pathways—MMP9—systemic lupus erythematosus	9.54e-06	0.000131	CbGpPWpGaD
Tacrolimus—PPP3CA—Signaling Pathways—CDKN1A—systemic lupus erythematosus	9.5e-06	0.000131	CbGpPWpGaD
Tacrolimus—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—systemic lupus erythematosus	9.49e-06	0.00013	CbGpPWpGaD
Tacrolimus—ALB—Hemostasis—F2—systemic lupus erythematosus	9.46e-06	0.00013	CbGpPWpGaD
Tacrolimus—FKBP1A—Signaling Pathways—TYK2—systemic lupus erythematosus	9.39e-06	0.000129	CbGpPWpGaD
Tacrolimus—FKBP1A—Signaling Pathways—NOS3—systemic lupus erythematosus	9.22e-06	0.000127	CbGpPWpGaD
Tacrolimus—PPP3CA—Immune System—IL6—systemic lupus erythematosus	9.16e-06	0.000126	CbGpPWpGaD
Tacrolimus—PPP3CA—Signaling Pathways—EP300—systemic lupus erythematosus	9.04e-06	0.000124	CbGpPWpGaD
Tacrolimus—CYP3A7—Metabolism—RXRA—systemic lupus erythematosus	9.01e-06	0.000124	CbGpPWpGaD
Tacrolimus—MTOR—Disease—CD80—systemic lupus erythematosus	8.93e-06	0.000123	CbGpPWpGaD
Tacrolimus—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—systemic lupus erythematosus	8.86e-06	0.000122	CbGpPWpGaD
Tacrolimus—ABCB1—Metabolism—NAT2—systemic lupus erythematosus	8.77e-06	0.000121	CbGpPWpGaD
Tacrolimus—FKBP1A—Disease—TGFB1—systemic lupus erythematosus	8.7e-06	0.00012	CbGpPWpGaD
Tacrolimus—PPP3CA—Signaling Pathways—VEGFA—systemic lupus erythematosus	8.56e-06	0.000118	CbGpPWpGaD
Tacrolimus—PPP3CA—Disease—IL6—systemic lupus erythematosus	8.46e-06	0.000116	CbGpPWpGaD
Tacrolimus—MTOR—Immune System—TYK2—systemic lupus erythematosus	8.17e-06	0.000112	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—JAK1—systemic lupus erythematosus	8.03e-06	0.00011	CbGpPWpGaD
Tacrolimus—FKBP1A—Signaling Pathways—CDKN1B—systemic lupus erythematosus	7.98e-06	0.00011	CbGpPWpGaD
Tacrolimus—ALB—Metabolism of lipids and lipoproteins—PPARG—systemic lupus erythematosus	7.95e-06	0.000109	CbGpPWpGaD
Tacrolimus—PPP3CA—Signaling Pathways—TGFB1—systemic lupus erythematosus	7.86e-06	0.000108	CbGpPWpGaD
Tacrolimus—FKBP1A—Signaling Pathways—IL2—systemic lupus erythematosus	7.81e-06	0.000107	CbGpPWpGaD
Tacrolimus—MTOR—Immune System—IFNG—systemic lupus erythematosus	7.65e-06	0.000105	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—CCR5—systemic lupus erythematosus	7.61e-06	0.000105	CbGpPWpGaD
Tacrolimus—MTOR—Disease—TYK2—systemic lupus erythematosus	7.54e-06	0.000104	CbGpPWpGaD
Tacrolimus—ALB—Hemostasis—NOS3—systemic lupus erythematosus	7.51e-06	0.000103	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—IL2RA—systemic lupus erythematosus	7.5e-06	0.000103	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—C3—systemic lupus erythematosus	7.43e-06	0.000102	CbGpPWpGaD
Tacrolimus—MTOR—Disease—NOS3—systemic lupus erythematosus	7.4e-06	0.000102	CbGpPWpGaD
Tacrolimus—FKBP1A—Signaling Pathways—MMP9—systemic lupus erythematosus	7.39e-06	0.000102	CbGpPWpGaD
Tacrolimus—MTOR—Immune System—CD4—systemic lupus erythematosus	7.39e-06	0.000102	CbGpPWpGaD
Tacrolimus—FKBP1A—Signaling Pathways—CDKN1A—systemic lupus erythematosus	7.37e-06	0.000101	CbGpPWpGaD
Tacrolimus—FKBP1A—Signaling Pathways—EP300—systemic lupus erythematosus	7.01e-06	9.64e-05	CbGpPWpGaD
Tacrolimus—MTOR—Immune System—CDKN1B—systemic lupus erythematosus	6.95e-06	9.55e-05	CbGpPWpGaD
Tacrolimus—MTOR—Innate Immune System—IL6—systemic lupus erythematosus	6.86e-06	9.43e-05	CbGpPWpGaD
Tacrolimus—MTOR—Disease—CD4—systemic lupus erythematosus	6.82e-06	9.38e-05	CbGpPWpGaD
Tacrolimus—MTOR—Immune System—IL2—systemic lupus erythematosus	6.8e-06	9.34e-05	CbGpPWpGaD
Tacrolimus—MTOR—Disease—PTGS2—systemic lupus erythematosus	6.77e-06	9.31e-05	CbGpPWpGaD
Tacrolimus—FKBP1A—Signaling Pathways—VEGFA—systemic lupus erythematosus	6.64e-06	9.13e-05	CbGpPWpGaD
Tacrolimus—FKBP1A—Disease—IL6—systemic lupus erythematosus	6.56e-06	9.02e-05	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—F2—systemic lupus erythematosus	6.53e-06	8.97e-05	CbGpPWpGaD
Tacrolimus—CYP3A5—Metabolism—RXRA—systemic lupus erythematosus	6.51e-06	8.95e-05	CbGpPWpGaD
Tacrolimus—MTOR—Disease—CDKN1B—systemic lupus erythematosus	6.41e-06	8.81e-05	CbGpPWpGaD
Tacrolimus—MTOR—Immune System—CDKN1A—systemic lupus erythematosus	6.41e-06	8.81e-05	CbGpPWpGaD
Tacrolimus—ALB—Hemostasis—IL2—systemic lupus erythematosus	6.37e-06	8.75e-05	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—CD80—systemic lupus erythematosus	6.26e-06	8.6e-05	CbGpPWpGaD
Tacrolimus—ALB—Metabolism of lipids and lipoproteins—PTGS2—systemic lupus erythematosus	6.26e-06	8.6e-05	CbGpPWpGaD
Tacrolimus—MTOR—Immune System—EP300—systemic lupus erythematosus	6.1e-06	8.38e-05	CbGpPWpGaD
Tacrolimus—FKBP1A—Signaling Pathways—TGFB1—systemic lupus erythematosus	6.09e-06	8.38e-05	CbGpPWpGaD
Tacrolimus—ABCB1—Transmembrane transport of small molecules—ALB—systemic lupus erythematosus	5.96e-06	8.19e-05	CbGpPWpGaD
Tacrolimus—PPP3CA—Signaling Pathways—IL6—systemic lupus erythematosus	5.92e-06	8.14e-05	CbGpPWpGaD
Tacrolimus—MTOR—Disease—CDKN1A—systemic lupus erythematosus	5.92e-06	8.13e-05	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—CCL2—systemic lupus erythematosus	5.82e-06	7.99e-05	CbGpPWpGaD
Tacrolimus—ALB—Hemostasis—EP300—systemic lupus erythematosus	5.71e-06	7.86e-05	CbGpPWpGaD
Tacrolimus—CYP3A7—Metabolism—PPARG—systemic lupus erythematosus	5.69e-06	7.82e-05	CbGpPWpGaD
Tacrolimus—MTOR—Disease—EP300—systemic lupus erythematosus	5.63e-06	7.74e-05	CbGpPWpGaD
Tacrolimus—ALB—Metabolism—RXRA—systemic lupus erythematosus	5.61e-06	7.71e-05	CbGpPWpGaD
Tacrolimus—ALB—Hemostasis—VEGFA—systemic lupus erythematosus	5.41e-06	7.44e-05	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—NAT2—systemic lupus erythematosus	5.4e-06	7.42e-05	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—TYK2—systemic lupus erythematosus	5.28e-06	7.26e-05	CbGpPWpGaD
Tacrolimus—ALB—Metabolism of lipids and lipoproteins—EP300—systemic lupus erythematosus	5.2e-06	7.15e-05	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—NOS3—systemic lupus erythematosus	5.18e-06	7.13e-05	CbGpPWpGaD
Tacrolimus—CYP3A7—Metabolism—ALB—systemic lupus erythematosus	5.12e-06	7.03e-05	CbGpPWpGaD
Tacrolimus—ALB—Hemostasis—TGFB1—systemic lupus erythematosus	4.97e-06	6.83e-05	CbGpPWpGaD
Tacrolimus—ABCB1—Metabolism—RXRA—systemic lupus erythematosus	4.91e-06	6.76e-05	CbGpPWpGaD
Tacrolimus—MTOR—Disease—TGFB1—systemic lupus erythematosus	4.89e-06	6.73e-05	CbGpPWpGaD
Tacrolimus—CYP3A7—Metabolism—NOS3—systemic lupus erythematosus	4.89e-06	6.73e-05	CbGpPWpGaD
Tacrolimus—FKBP1A—Signaling Pathways—IL6—systemic lupus erythematosus	4.59e-06	6.31e-05	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—CDKN1B—systemic lupus erythematosus	4.49e-06	6.17e-05	CbGpPWpGaD
Tacrolimus—CYP3A7—Metabolism—PTGS2—systemic lupus erythematosus	4.48e-06	6.15e-05	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—IL2—systemic lupus erythematosus	4.39e-06	6.04e-05	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—MMP9—systemic lupus erythematosus	4.16e-06	5.72e-05	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—CDKN1A—systemic lupus erythematosus	4.14e-06	5.7e-05	CbGpPWpGaD
Tacrolimus—CYP3A5—Metabolism—PPARG—systemic lupus erythematosus	4.11e-06	5.65e-05	CbGpPWpGaD
Tacrolimus—MTOR—Immune System—IL6—systemic lupus erythematosus	4e-06	5.49e-05	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—EP300—systemic lupus erythematosus	3.94e-06	5.42e-05	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—VEGFA—systemic lupus erythematosus	3.73e-06	5.13e-05	CbGpPWpGaD
Tacrolimus—CYP3A7—Metabolism—EP300—systemic lupus erythematosus	3.72e-06	5.12e-05	CbGpPWpGaD
Tacrolimus—CYP3A5—Metabolism—ALB—systemic lupus erythematosus	3.7e-06	5.08e-05	CbGpPWpGaD
Tacrolimus—MTOR—Disease—IL6—systemic lupus erythematosus	3.69e-06	5.07e-05	CbGpPWpGaD
Tacrolimus—ALB—Metabolism—PPARG—systemic lupus erythematosus	3.54e-06	4.87e-05	CbGpPWpGaD
Tacrolimus—CYP3A5—Metabolism—NOS3—systemic lupus erythematosus	3.54e-06	4.86e-05	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—TGFB1—systemic lupus erythematosus	3.43e-06	4.71e-05	CbGpPWpGaD
Tacrolimus—CYP3A5—Metabolism—PTGS2—systemic lupus erythematosus	3.23e-06	4.45e-05	CbGpPWpGaD
Tacrolimus—ABCB1—Metabolism—PPARG—systemic lupus erythematosus	3.1e-06	4.27e-05	CbGpPWpGaD
Tacrolimus—ALB—Metabolism—NOS3—systemic lupus erythematosus	3.05e-06	4.19e-05	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—RXRA—systemic lupus erythematosus	3.03e-06	4.16e-05	CbGpPWpGaD
Tacrolimus—ABCB1—Metabolism—ALB—systemic lupus erythematosus	2.79e-06	3.84e-05	CbGpPWpGaD
Tacrolimus—ALB—Metabolism—PTGS2—systemic lupus erythematosus	2.79e-06	3.83e-05	CbGpPWpGaD
Tacrolimus—CYP3A5—Metabolism—EP300—systemic lupus erythematosus	2.69e-06	3.7e-05	CbGpPWpGaD
Tacrolimus—ABCB1—Metabolism—NOS3—systemic lupus erythematosus	2.67e-06	3.67e-05	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—IL6—systemic lupus erythematosus	2.58e-06	3.55e-05	CbGpPWpGaD
Tacrolimus—ABCB1—Metabolism—PTGS2—systemic lupus erythematosus	2.44e-06	3.36e-05	CbGpPWpGaD
Tacrolimus—ALB—Metabolism—EP300—systemic lupus erythematosus	2.32e-06	3.19e-05	CbGpPWpGaD
Tacrolimus—ABCB1—Metabolism—EP300—systemic lupus erythematosus	2.03e-06	2.79e-05	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—PPARG—systemic lupus erythematosus	1.91e-06	2.63e-05	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—ALB—systemic lupus erythematosus	1.72e-06	2.36e-05	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—NOS3—systemic lupus erythematosus	1.64e-06	2.26e-05	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—PTGS2—systemic lupus erythematosus	1.5e-06	2.07e-05	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—EP300—systemic lupus erythematosus	1.25e-06	1.72e-05	CbGpPWpGaD
